Rajat Walia

3.3k total citations
91 papers, 915 citations indexed

About

Rajat Walia is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Rajat Walia has authored 91 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Surgery, 31 papers in Pulmonary and Respiratory Medicine and 31 papers in Epidemiology. Recurrent topics in Rajat Walia's work include Transplantation: Methods and Outcomes (58 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers) and Polyomavirus and related diseases (14 papers). Rajat Walia is often cited by papers focused on Transplantation: Methods and Outcomes (58 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers) and Polyomavirus and related diseases (14 papers). Rajat Walia collaborates with scholars based in United States, India and Australia. Rajat Walia's co-authors include Ross M. Bremner, Michael A. Smith, Thalachallour Mohanakumar, Jasmine Huang, Sofya Tokman, Robert A. Zlotecki, A. Arjuna, Alan T. Monroe, Michael A. Jantz and Ramsey R. Hachem and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Rajat Walia

74 papers receiving 902 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajat Walia United States 16 443 275 244 230 198 91 915
David A. Waltz United States 10 536 1.2× 189 0.7× 556 2.3× 261 1.1× 110 0.6× 11 1.3k
David R. Nunley United States 17 537 1.2× 278 1.0× 391 1.6× 61 0.3× 137 0.7× 48 921
C. Amrein France 17 458 1.0× 183 0.7× 146 0.6× 112 0.5× 167 0.8× 53 1.0k
V. Boussaud France 18 230 0.5× 305 1.1× 312 1.3× 65 0.3× 298 1.5× 46 822
Olivier Baron France 16 363 0.8× 276 1.0× 249 1.0× 113 0.5× 39 0.2× 53 826
Wayne F. Grgurich United States 18 728 1.6× 450 1.6× 437 1.8× 47 0.2× 127 0.6× 25 1.2k
S.G. LaPlace United States 13 234 0.5× 206 0.7× 196 0.8× 78 0.3× 78 0.4× 20 551
Philippe Despins France 16 541 1.2× 197 0.7× 262 1.1× 27 0.1× 144 0.7× 39 895
Daniel F. Dilling United States 18 342 0.8× 189 0.7× 310 1.3× 92 0.4× 94 0.5× 48 861
Cristina Berastegui Spain 16 386 0.9× 268 1.0× 189 0.8× 23 0.1× 171 0.9× 68 682

Countries citing papers authored by Rajat Walia

Since Specialization
Citations

This map shows the geographic impact of Rajat Walia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajat Walia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajat Walia more than expected).

Fields of papers citing papers by Rajat Walia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajat Walia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajat Walia. The network helps show where Rajat Walia may publish in the future.

Co-authorship network of co-authors of Rajat Walia

This figure shows the co-authorship network connecting the top 25 collaborators of Rajat Walia. A scholar is included among the top collaborators of Rajat Walia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajat Walia. Rajat Walia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woods, Christopher W., et al.. (2025). Incidental Finding of Metastatic Adenocarcinoma of Unknown Primary Origin in a Lung Transplant Candidate With Rapidly Progressive Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A6010–A6010.
2.
Wang, Lucas, Sreeja Biswas Roy, A. Arjuna, et al.. (2025). Lung Transplantation in the Elderly: Is Age a Contraindication?. The Annals of Thoracic Surgery. 121(2). 311–319.
3.
Nailor, Michael D., et al.. (2024). Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. Transplant Infectious Disease. 26(3). e14279–e14279. 5 indexed citations
4.
Bay, R. Curtis, et al.. (2024). Clinical utility of plasma percent donor-derived cell-free DNA for lung allograft surveillance: A real-world single-center experience. SHILAP Revista de lepidopterología. 6. 100141–100141. 1 indexed citations
5.
6.
Natri, Heini M., Christina B. Azodi, Lance Peter, et al.. (2024). Cell-type-specific and disease-associated expression quantitative trait loci in the human lung. Nature Genetics. 56(4). 595–604. 16 indexed citations
7.
8.
Walia, Rajat, et al.. (2024). Remdesivir and molnupiravir had comparable efficacy in lung transplant recipients with mild-to-moderate COVID-19: a single center experience. SHILAP Revista de lepidopterología. 3. 1408289–1408289. 1 indexed citations
9.
Olson, M.T., Rajat Walia, Hesham Mohamed, & A. Arjuna. (2023). Nodular Consolidations as a Manifestation of Chronic Rejection Physiology in a Lung Transplant Recipient. A3561–A3561.
10.
Hu, Chengcheng, et al.. (2022). Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients. Transplant Immunology. 75. 101703–101703. 3 indexed citations
11.
Chapple, Kristina, et al.. (2021). Efficacy of low-dose valganciclovir in Cytomegalovirus R+ lung transplant recipients: a retrospective comparative analysis. Multidisciplinary Respiratory Medicine. 16(1). 706–706. 5 indexed citations
12.
Olson, M.T., Sreeja Biswas Roy, Paul Kang, et al.. (2021). Outcomes after lung transplantation in recipients aged 70 years or older. Clinical Transplantation. 36(1). e14505–e14505. 8 indexed citations
13.
Goodlet, Kellie J., et al.. (2020). Nocardia prophylaxis, treatment, and outcomes of infection in lung transplant recipients: A matched case‐control study. Transplant Infectious Disease. 23(2). e13478–e13478. 20 indexed citations
14.
Olson, M.T., Paul Kang, Takahiro Masuda, et al.. (2019). Factors associated with skin cancer in lung transplant recipients: A single‐center experience. Clinical Transplantation. 33(12). e13718–e13718. 10 indexed citations
15.
Yerasi, Charan, Sreeja Biswas Roy, M.T. Olson, et al.. (2018). Outcomes of lung transplant recipients with preoperative atrial fibrillation. Asian Cardiovascular and Thoracic Annals. 26(2). 127–132. 8 indexed citations
16.
Tokman, Sofya, et al.. (2016). Lung Transplant Recipient with Pulmonary Alveolar Proteinosis. SHILAP Revista de lepidopterología. 2016. 1–4. 9 indexed citations
17.
Hodges, Tony N., et al.. (2011). Hardware Preservation After Sternal Wound Infection in a Lung Transplant Recipient. The Annals of Thoracic Surgery. 92(2). 718–720. 2 indexed citations
18.
Weinkauf, J., Rajat Walia, Gerald J. Berry, Randall H. Vagelos, & John L. Faul. (2005). Lymphocytic Myocarditis After Lung Transplantation. The Journal of Heart and Lung Transplantation. 24(8). 1163–1165. 3 indexed citations
19.
Monroe, Alan T., Rajat Walia, Robert A. Zlotecki, & Michael A. Jantz. (2004). Tracheobronchial Amyloidosis. CHEST Journal. 125(2). 784–789. 58 indexed citations
20.
Rani, Rajni, Sidra Zaheer, Rajat Walia, et al.. (1992). Association of HLA antigens with differential responsiveness toMycobacterium w vaccine in multibacillary leprosy patients. Journal of Clinical Immunology. 12(1). 50–55. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David A. Waltz Breakdown of academic impact, for papers by David R. Nunley Breakdown of academic impact, for papers by C. Amrein Breakdown of academic impact, for papers by V. Boussaud Breakdown of academic impact, for papers by Olivier Baron Breakdown of academic impact, for papers by Wayne F. Grgurich Breakdown of academic impact, for papers by S.G. LaPlace Breakdown of academic impact, for papers by Philippe Despins Breakdown of academic impact, for papers by Daniel F. Dilling Breakdown of academic impact, for papers by Cristina Berastegui
Rankless by CCL
2026